Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in squamous cell carcinoma of the penis

Urology

Volumn 68, Issue 1, 2006, Pages 205-207

  Hudolin, Tvrtko ^a   Juretic, Antonio ^a   Pasini, Josip ^a   Tomas, Davor ^b   Spagnoli, Giulio Cesare ^c   Heberer, Michael ^c   Dimanovski, Jordan ^b   Kruslin, Bozo ^b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER TESTIS ANTIGEN; MELANOMA ANTIGEN; MELANOMA ANTIGEN 1; MELANOMA ANTIGEN 3; MELANOMA ANTIGEN 4; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 57B; MONOCLONAL ANTIBODY 77B; MONOCLONAL ANTIBODY D8.38; NY ESO 1 ANTIGEN; REAGENT; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ARTICLE; CANCER PATIENT; CELL HETEROGENEITY; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYTOPLASM; HOSPITAL DEPARTMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PENIS AMPUTATION; PENIS CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STAINING; TIME SERIES ANALYSIS; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PENILE NEOPLASMS; TESTIS;

EID: 33745808388     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.01.033     Document Type: Article

References (14)

1. Ornellas A.A., Seixas A.L., Marota A., et al. Surgical treatment of invasive squamous cell carcinoma of the penis. retrospective analysis of 350 cases. J Urol 151 (1994) 1244-1249
2. Zendman A.J., Ruiter D.J., and Van Muijen G.N. Cancer/testis-associated genes. identification, expression profile, and putative function. J Cell Physiol 194 (2003) 272-288
3. Marchand M., Punt C.J., Aamdal S., et al. Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2. a clinical report. Eur J Cancer 39 (2003) 70-77
4. Thurner B., Haendle I., Roder C., et al. Vaccination with MAGE-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med 190 (1999) 1669-1678
5. Nestle F.O., Alijagic S., Gilliet M., et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 4 (1998) 328-332
6. Kocher T., Zheng M., Bolli M., et al. Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder. a tissue microarray study. Int J Cancer 100 (2002) 702-705
7. Fossa A., Berner A., Fossa S.D., et al. NY-ESO-1 protein expression and humoral immune responses in prostate cancer. Prostate 59 (2004) 440-447
8. Hudolin T., Juretic A., Spagnoli G.C., et al. Immunohistochemical expression of tumour antigens MAGE-A1, MAGE-A3/4 and NY-ESO-1 in cancerous and benign prostatic tissue. Prostate 66 (2006) 13-18
9. Juretic A., Spagnoli G.C., Schultz-Thater E., et al. Cancer/testis tumour-associated antigens. immunohistochemical detection with monoclonal antibodies. Lancet Oncol 4 (2003) 104-109
10. Schultz-Thater E., Juretic A., Dellabona P., et al. MAGE-1 gene product is a cytoplasmic protein. Int J Cancer 59 (1994) 435-439
11. Kocher T., Schultz-Thater E., Gudat F., et al. Identification and intracellular location of MAGE-3 gene product. Cancer Res 55 (1995) 2236-2239
12. Schultz-Thater E., Noppen C., Gudat F., et al. NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimens. Br J Cancer 83 (2000) 204-208
13. Jungbluth A.A., Chen Y.T., Stockert E., et al. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer 92 (2001) 856-860
14. Fischer C., Gudat F., Stulz P., et al. High expression of MAGE-3 protein in squamous-cell lung carcinoma. Int J Cancer 71 (1997) 1119-1121